Cargando…
High Levels of Proinflammatory Cytokines, but Not Markers of Tissue Injury, in Unaffected Intestinal Areas from Patients with IBD
Intestinal alterations in IBD are triggered and maintained by an overexpression of proinflammatory cytokines. Additionally, increased immune activation has been found in the adjacent intestinal areas without displaying any apparent histological alterations, however, the regulatory environment is not...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2719754/ https://www.ncbi.nlm.nih.gov/pubmed/19657406 http://dx.doi.org/10.1155/2009/580450 |
_version_ | 1782170101218279424 |
---|---|
author | León, Alberto J. Gómez, Emma Garrote, Jose A. Bernardo, David Barrera, Asterio Marcos, Jose L. Fernández-Salazar, Luis Velayos, Benito Blanco-Quirós, Alfredo Arranz, Eduardo |
author_facet | León, Alberto J. Gómez, Emma Garrote, Jose A. Bernardo, David Barrera, Asterio Marcos, Jose L. Fernández-Salazar, Luis Velayos, Benito Blanco-Quirós, Alfredo Arranz, Eduardo |
author_sort | León, Alberto J. |
collection | PubMed |
description | Intestinal alterations in IBD are triggered and maintained by an overexpression of proinflammatory cytokines. Additionally, increased immune activation has been found in the adjacent intestinal areas without displaying any apparent histological alterations, however, the regulatory environment is not well established. Biopsy specimens from patients with ulcerative colitis (UC) and Crohn's disease (CD), from both affected and unaffected areas, and also from a group of colonic biopsies from healthy controls, were included in our study. Cytokines and markers of mucosal damage were analyzed by real-time PCR, and some of the results confirmed by western-blot and ELISA. Levels of IFNγ, TNFα, IL-6, IL-15, IL-18, and IL-23 were increased (above healthy controls) in both affected and unaffected areas from IBD. IL-1β, IL-6, IL-12, and IL-27 were higher in affected areas compared to unaffected ones in UC but not CD. In general, a correlation was observed between mRNA levels of these cytokines and both iNOS and Granzyme B. SOCS-2 and SOCS-3 were also increased in the affected areas. In conclusion, the unaffected areas from IBD show increased levels of a restricted set of cytokines that may exert immune activating roles in these areas without being able to trigger tissue damage. |
format | Text |
id | pubmed-2719754 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-27197542009-08-05 High Levels of Proinflammatory Cytokines, but Not Markers of Tissue Injury, in Unaffected Intestinal Areas from Patients with IBD León, Alberto J. Gómez, Emma Garrote, Jose A. Bernardo, David Barrera, Asterio Marcos, Jose L. Fernández-Salazar, Luis Velayos, Benito Blanco-Quirós, Alfredo Arranz, Eduardo Mediators Inflamm Research Article Intestinal alterations in IBD are triggered and maintained by an overexpression of proinflammatory cytokines. Additionally, increased immune activation has been found in the adjacent intestinal areas without displaying any apparent histological alterations, however, the regulatory environment is not well established. Biopsy specimens from patients with ulcerative colitis (UC) and Crohn's disease (CD), from both affected and unaffected areas, and also from a group of colonic biopsies from healthy controls, were included in our study. Cytokines and markers of mucosal damage were analyzed by real-time PCR, and some of the results confirmed by western-blot and ELISA. Levels of IFNγ, TNFα, IL-6, IL-15, IL-18, and IL-23 were increased (above healthy controls) in both affected and unaffected areas from IBD. IL-1β, IL-6, IL-12, and IL-27 were higher in affected areas compared to unaffected ones in UC but not CD. In general, a correlation was observed between mRNA levels of these cytokines and both iNOS and Granzyme B. SOCS-2 and SOCS-3 were also increased in the affected areas. In conclusion, the unaffected areas from IBD show increased levels of a restricted set of cytokines that may exert immune activating roles in these areas without being able to trigger tissue damage. Hindawi Publishing Corporation 2009 2009-07-30 /pmc/articles/PMC2719754/ /pubmed/19657406 http://dx.doi.org/10.1155/2009/580450 Text en Copyright © 2009 Alberto J. León et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article León, Alberto J. Gómez, Emma Garrote, Jose A. Bernardo, David Barrera, Asterio Marcos, Jose L. Fernández-Salazar, Luis Velayos, Benito Blanco-Quirós, Alfredo Arranz, Eduardo High Levels of Proinflammatory Cytokines, but Not Markers of Tissue Injury, in Unaffected Intestinal Areas from Patients with IBD |
title | High Levels of Proinflammatory Cytokines, but Not Markers of Tissue Injury, in Unaffected Intestinal Areas from Patients with IBD |
title_full | High Levels of Proinflammatory Cytokines, but Not Markers of Tissue Injury, in Unaffected Intestinal Areas from Patients with IBD |
title_fullStr | High Levels of Proinflammatory Cytokines, but Not Markers of Tissue Injury, in Unaffected Intestinal Areas from Patients with IBD |
title_full_unstemmed | High Levels of Proinflammatory Cytokines, but Not Markers of Tissue Injury, in Unaffected Intestinal Areas from Patients with IBD |
title_short | High Levels of Proinflammatory Cytokines, but Not Markers of Tissue Injury, in Unaffected Intestinal Areas from Patients with IBD |
title_sort | high levels of proinflammatory cytokines, but not markers of tissue injury, in unaffected intestinal areas from patients with ibd |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2719754/ https://www.ncbi.nlm.nih.gov/pubmed/19657406 http://dx.doi.org/10.1155/2009/580450 |
work_keys_str_mv | AT leonalbertoj highlevelsofproinflammatorycytokinesbutnotmarkersoftissueinjuryinunaffectedintestinalareasfrompatientswithibd AT gomezemma highlevelsofproinflammatorycytokinesbutnotmarkersoftissueinjuryinunaffectedintestinalareasfrompatientswithibd AT garrotejosea highlevelsofproinflammatorycytokinesbutnotmarkersoftissueinjuryinunaffectedintestinalareasfrompatientswithibd AT bernardodavid highlevelsofproinflammatorycytokinesbutnotmarkersoftissueinjuryinunaffectedintestinalareasfrompatientswithibd AT barreraasterio highlevelsofproinflammatorycytokinesbutnotmarkersoftissueinjuryinunaffectedintestinalareasfrompatientswithibd AT marcosjosel highlevelsofproinflammatorycytokinesbutnotmarkersoftissueinjuryinunaffectedintestinalareasfrompatientswithibd AT fernandezsalazarluis highlevelsofproinflammatorycytokinesbutnotmarkersoftissueinjuryinunaffectedintestinalareasfrompatientswithibd AT velayosbenito highlevelsofproinflammatorycytokinesbutnotmarkersoftissueinjuryinunaffectedintestinalareasfrompatientswithibd AT blancoquirosalfredo highlevelsofproinflammatorycytokinesbutnotmarkersoftissueinjuryinunaffectedintestinalareasfrompatientswithibd AT arranzeduardo highlevelsofproinflammatorycytokinesbutnotmarkersoftissueinjuryinunaffectedintestinalareasfrompatientswithibd |